Fennec Pharmaceuticals (FENC) EBITDA (1997 - 2026)
Fennec Pharmaceuticals (FENC) EBITDA from Jun 30, 1997 to Mar 31, 2026. The TTM Fennec Pharmaceuticals (FENC) EBITDA is -$6.77M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Fennec Pharmaceuticals (FENC) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -35.15% |
| 3 Years TTM | -36.20% |
| 5 Years TTM | -15.56% |
| 10 Years TTM | +18.40% |
| All Time TTM | +10.73% |
Annual EBITDA change of Fennec Pharmaceuticals (FENC)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $210K | -102.78% |
| 2025 | -$7.55M | -288.75% |
| 2024 | $4M | -131.62% |
| 2023 | -$13M | -46.65% |
| 2022 | -$24M | +36.66% |
| 2021 | -$17M | -4.20% |
| 2020 | -$18M | +41.82% |
| 2019 | -$13M | +29.12% |
| 2018 | -$9.89M | +40.28% |
| 2017 | -$7.05M | +152.69% |
| 2016 | -$2.79M | +322.73% |
| 2015 | -$660K | -69.72% |
| 2014 | -$2.18M | +12.95% |
| 2013 | -$1.93M | -46.69% |
| 2012 | -$3.62M | +5.23% |
| 2011 | -$3.44M | -56.01% |
| 2010 | -$7.82M | +159.80% |
| 2009 | -$3.01M | -77.87% |
| 2008 | -$14M | +1.80% |
| 2007 | -$13M | -18.73% |
| 2006 | -$16M | +18.53% |
| 2005 | -$14M | +101.89% |
| 2004 | -$6.87M | -61.40% |
| 2003 | -$18M | +377.21% |
| 2002 | -$3.73M | +48.02% |
| 2001 | -$2.52M | +57.50% |
| 2000 | -$1.60M | +66.67% |
| 1999 | -$960K | +140.00% |
| 1998 | -$400K | +900.00% |
| 1997 | -$40K | N/A |
Comparison Fennec Pharmaceuticals (FENC) five years EBITDA CAGR with competitors
Fennec Pharmaceuticals (FENC) five years EBITDA CAGR is -15.56%.